The Dermatology Digest

JULY 26, 2024

The resubmission has been accepted as a complete response to the FDA’s December 2023 complete response letter (CRL) and the FDA has set a Prescription Drug User Fee Act (PDUFA) goal date of December 28, 2024. The CRL did not state any concerns about the clinical data package, safety, or labeling for the approvability of cosibelimab.

Treatments 36

Treatments Surgery Safety Clinic 36

Aesthetics Advisor

NOVEMBER 7, 2023

Mouthwash is part of the FLCCC I-PREVENT Protocol Best Mouthwashes for COVID-19 according to evidence for 2023 There are lots of great mouthwashes out there, and this list is by no means complete. We’ve included therapeutic mouthwashes with proven anti-COVID-19 ingredient, you can buy over the counter.

Ingredients 69

Ingredients Irritation Sanitation Medical 69

The Dermatology Digest

MARCH 5, 2024

.” Coral Gables, FL-based dermatologist Joely Kaufman, MD, adds, “The results from the clinical trials for letibotulinumtoxinA demonstrate efficacy, and a convincing safety profile in the treatment of glabellar lines. Hugel resubmitted its application in October 2022 and was denied approval again in 2023. and Europe.

Branding 74

Branding Injections Safety Facials 74

Les Nouvelles Esthetics & Spa

JANUARY 31, 2024

We invest heavily in their training, focusing on the intricacies of our products and safety protocols. Without the burden of licensing requirements, we’ve fostered a diverse group of talented individuals. For many, Pure Glow has been a stepping stone to greater achievements in the beauty industry. What is your plan for company growth?

Branding 78

Branding Sales Office Safety 78

The Dermatology Digest

APRIL 4, 2024

The safety profile of Bimzelx was consistent with previous studies with no new safety signals observed. in October 2023 for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. In addition, improvements increased for patients in these studies over 48 weeks.

Safety 57

Safety Injections Clinic Therapy 57

Aesthetics Advisor

DECEMBER 14, 2023

For almost 90% of the most common pesticides, the agency has neglected to apply the Food Quality Protection Act–mandated children’s health safety factor to the allowable limits. Newcomers on the Dirty Dozen list for 2023 are blueberries and green beans, now ranked as No. Strawberries have remained in the No. 12, respectively.

Diet 36

Diet Document Download Safety 36

The Dermatology Digest

APRIL 30, 2024

Lebrikizumab Timeline October 2023 The U.S. There were no concerns with lebrikizumab’s clinical data package, safety, or label.

Dermatitis 36

Dermatitis Safety Clinic Dermatology 36

The Dermatology Digest

JANUARY 29, 2024

Food and Drug Administration (FDA) for treatment of seborrheic dermatitis in adult and pediatric patients 9 years of age and older in December 2023. Zoryve foam was well-tolerated with a favorable safety and tolerability profile. It is the first drug approved for seborrheic dermatitis with a new mechanism of action in over two decades.

Dermatitis 74

Dermatitis Safety Dermatology Treatments 74

The Dermatology Digest

FEBRUARY 8, 2024

In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. The BIG story is Janus kinase ( JAK ) inhibitors,” Dr. Martin says.

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

The Dermatology Digest

JULY 10, 2024

The treatment was approved by the European Commission and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) in December 2023. The letter stated no concerns about the clinical data package, safety, or label for lebrikizumab.

Dermatitis 36

Dermatitis Safety Dermatology Marketing 36

Aesthetics Advisor

AUGUST 7, 2023

The 2023 report from the World Obesity Federation estimates that the economic impact of overweight and obesity will surpass $4.3 In April 2023, a spokesperson for Novo Nordisk, maker of semaglutide, said the drugs are now available in pharmacies nationwide. A broad range of drug interventions can help. trillion annually by 2035.

Diet 36

Diet Extractions Medical Sustainability 36

The Dermatology Digest

MARCH 22, 2024

1,2 Benzene has become a more recent focus of attention related to safety concerns, with an increase in independent product testing and also updated regulations by the Food and Drug Administration related to benzene. Public safety is the first priority of the AARS. Right now, there are many questions about this issue. pp 9767-9777.

Rosacea 64

Rosacea Document Safety Ingredients 64

The Eco Well Blog

JUNE 14, 2024

2023), when consumers had the option between “mineral” and “chemical” sunscreens, when blinded, overwhelmingly they preferred the “chemical” sunscreen. So now we’re okay with less safety data over an ingredient that has more safety data? Sunscreen application, safety, and sun protection: the evidence. Colantonio, S.,

Sun Protection 52

Sun Protection Safety Ingredients Marketing 52

The Dermatology Digest

FEBRUARY 14, 2024

This follows its designation as a Breakthrough Therapy for the treatment of pruritus associated with prurigo nodularis, originally granted in December 2019 and reconfirmed in March 2023. Nemolizumab was generally well tolerated and its safety profile was similar to placebo across the OLYMPIA and ARCADIA clinical trial programs.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

Aesthetics Advisor

APRIL 26, 2024

As this substance infiltrates the American food supply, the potential risks to our health and future generations loom larger, raising urgent questions about the safety of our everyday food choices. In April of 2023, the EPA proposed allowing the first-ever use of chlormequat on barley, oat, wheat, and triticale grown in the United States.

Document 36

Document Safety Sales Diet 36

The Dermatology Digest

MAY 1, 2024

The low-concentration (50 mg/mL), citrate-free formulation of Cyltezo has been commercially available since July 2023. “Biologics and biosimilars are a crucial treatment option for many living with psoriatic arthritis or psoriasis,” says Leah M.

Clinic 36

Clinic Injections Safety Branding 36

The Dermatology Digest

MARCH 11, 2024

This follows its designation as a Breakthrough Therapy for the treatment of pruritus associated with prurigo nodularis, originally granted in December 2019 and reconfirmed in March 2023. No new safety signals were observed in this trial.

Dermatitis 36

Dermatitis Safety Dermatology Eczema 36

Aesthetics Advisor

APRIL 9, 2024

from 2023 to 2033. The market stands at a valuation of US 12 billion in 2023 and is expected to reach US 20 billion by 2033-end. Safety and side effects of olive oil Olive oil is generally safe and well-tolerated, but it may interact with certain medications (see Concerns and Cautions ). Let's dive in. What is avocado oil?

Marketing 36

Marketing Safety Extractions Medical 36

The Dermatology Digest

FEBRUARY 7, 2024

The total duration of the trial was up to 24 weeks, which included a four-week screening period, a 16-week treatment period and a four-week safety follow-up period. and Janssen Biotech, Inc. The findings from the FRONTIER 1 clinical trial suggest the potential of JNJ-2113 across the spectrum of additional IL-23-mediated diseases.

Safety 36

Safety Clinic Office Dermatology 36

Aesthetics Advisor

AUGUST 6, 2023

More research is being done to determine the safety of the keto diet in the long term. Anyone taking this medication should avoid the keto diet ( 40 Trusted Source , 41 Trusted Source ). Keep your doctor informed of your eating plan to guide your choices.

Diet 36

Diet Medical Management Sustainability 36

The Dermatology Digest

JANUARY 4, 2024

The clinical results demonstrated that DMB-3115 and its reference product, ustekinumab, are highly similar, and have no clinically meaningful differences in terms of quality, safety and efficacy. In October of 2023, Accord BioPharma reached a settlement with Janssen Biotech Inc., commercialization.

Pharmaceutical 36

Pharmaceutical Partnerships Clinic Safety 36

New Age Spa Institute

JUNE 8, 2023

INGLOT places importance on ingredient safety, ethical practices and sustainability. The next full-time professional makeup certification is from August 21, 2023 to August 31, 2023, Monday through Thursday, 9:00 a.m. They also offer a wide selection of vegan and cruelty-free cosmetic options. to 5:00 p.m. to 5:00 p.m.

Makeup 52

Makeup Training Esthetics Social Media 52

Associated Skin Care Professionals

AUGUST 16, 2023

In addition to its goal of eliminating toxic beauty standards and empowering youth, the Dove Self Esteem Project also announced its plans to address the rise in youth mental health issues linked to social media with the Campaign for Kids Online Safety. 80% of young people believe people their age are addicted to social media. 

Social Media 40

Social Media Partnerships Branding Education 40

Aesthetics Advisor

JULY 21, 2024

The Council has urged manufacturers to enhance product safety measures, and advised consumers to exercise caution when selecting and using hair styling products. 1, 2023, to combat air pollution. The Council urged suppliers to improve product labeling for consumer safety.

Waxing 36

Waxing Sensitive Skin Eczema Pores 36

Aesthetics Advisor

JANUARY 6, 2024

In November 2023, researchers from Cardiff University in the United Kingdom published a comprehensive review in the British Journal of Cancer (BJC) outlining aspirin’s potential to reduce cancer mortality, prevent metastatic cancer spread, and minimize vascular complications.

Vitamin C 36

Vitamin C Safety Therapy Networking 36

The Dermatology Digest

DECEMBER 18, 2023

The new AD guidelines also: • Highlight the safety of the topical calcineurin inhibitors with typical usage once or twice daily. The 2023 JTFPP atopic dermatitis guideline represents an advancement in trustworthy allergy guidelines,” says allergist Derek Chu, MD., Urge consideration for once-daily dosing of topical medications.

Dermatitis 36

Dermatitis Partnerships Therapy Safety 36

The Dermatology Digest

JULY 21, 2023

The safety profile for ruxolitinib cream was excellent, he said. Safety was excellent, with side effects similar to placebo, said Dr. Pandya. Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial [published correction appears in J Am Acad Dermatol.

Treatments 36

Treatments Safety Medical Clinic 36

Aesthetics Advisor

FEBRUARY 21, 2024

I grabbed a ChatGPT account on the first day it was available in November 2023, because I recognized that it eclipsed the internet in terms of its revolutionary impact. For example, in October 2023, the U.S. Sources and References 1 The Conversation February 8, 2023 2 OpenAI Privacy Policy.

Tools 36

Tools Technology Legal Education 36

Aesthetics Advisor

JUNE 3, 2024

in 2023, according to a report1 from the American Journal of Health-System Pharmacy. 2017 Dec;2(12):890-899 14 GoodRx, Wegovy 15 American Society of Plastic Surgeons, November 13, 2023 19 J Investig Med High Impact Case Rep. 2023;330(18):1795-1797 22 Expert Opinion on Drug Safety, 22(6), 455–461 23 Int J Clin Pharm.

Surgery 36

Surgery Diet Pharmaceutical Medical 36

The Dermatology Digest

JANUARY 10, 2024

Positive clinical data from the Phase 1b trial were announced in October 2023. The trial was a 16-week open-label study assessing the safety, tolerability, pharmacokinetics, and exploratory efficacy of once-daily topical VYN201 in 29 patients with a clinical diagnosis of active nonsegmental vitiligo, in three dose cohorts (0.5%, 1.0%

Clinic 36

Clinic Safety Dermatology Treatments 36

The Dermatology Digest

OCTOBER 5, 2023

” session at the 2023 AAD Innovation Academy in Tampa, Florida. “I The DNA Connection Deep in our DNA, there’s a primordial theme of slowing down, connection, and safety, said Dr. Barr. Essentially a resource is anything that helps you and your patients feel a sense of safety and support.

Safety 36

Safety Social Media Therapy Sun Protection 36

The Dermatology Digest

DECEMBER 21, 2023

This is the main takeaway message from a new study in the December 21, 2023, issue of Cell. Janus kinase (JAK) inhibitors are revolutionizing the way certain inflammatory diseases such as atopic dermatitis (AD) are being treated, but a more nuanced approach may be needed in modulating JAK activity for conditions like asthma.

Dermatitis 36

Dermatitis Eczema Safety Dermatology 36

First Derm

JANUARY 16, 2024

Patient Safety and Success : Prioritizing skin cancer screening helps in safeguarding patient health, significantly enhancing the safety and success rates of cosmetic procedures. Compromised surgical outcomes: Performing cosmetic procedures on skin with undetected cancer can compromise the safety and effectiveness of the surgery.

Surgery 59

Surgery Scarring Safety Treatments 59

Aesthetic Advancements Institute (AAI)

JUNE 20, 2023

Juvéderm’s® newest filler, Volux , has been approved by the FDA and is set to hit medical offices in early 2023. There is a new dermal filler on the market! This new filler is designed to specifically target the jawline, an area of concern for many consumers seeking facial sculpting and contouring.

Training 36

Training Injections Medical Facials 36

Aesthetics Advisor

AUGUST 6, 2023

The safety of artificial sweeteners has long stirred a heated debate. Francesco Branca, WHO Director for Nutrition and Food Safety, stated, “Replacing free sugars with NSS does not help with weight control in the long term. Artificial sweeteners are used in food processing and beverages to replace real sugar.

Diet 36

Diet Safety Tools Branding 36

Aesthetics Advisor

DECEMBER 6, 2023

But recent survey findings published in the Journal of the American Medical Association (JAMA) Pediatrics (2023) suggest that melatonin consumption in U.S. I suspect the biggest issue is easy access to melatonin and its ill-perceived safety,” sleep medicine pediatrician Dr. Muhammad A. children and adolescents is “exceedingly common.”

Safety 36

Safety Pharmaceutical Social Media Hospital 36

The Dermatology Digest

APRIL 23, 2024

Symptom onset dates ranged from November 4, 2023, to March 31, 2024. Report adverse events related to the use of any medications, including suspected counterfeit medications, to FDA’s MedWatch Safety Information and Adverse Event Reporting Program. All symptomatic people were females aged 25 to 59 years.

Injections 36

Injections Hospital Clinic Consultation 36